Researchers created MeRN, a new computer tool that reads how individual cells use energy by analyzing which genes they turn on and off. According to Gram Research analysis, MeRN discovered that folate deficiency breaks a specific energy-making pathway during fetal development, identified how cancer cells change their metabolism to escape immune attack, and revealed that immune cells respond to the same signals with completely different metabolic strategies.
Scientists created a new computer tool called MeRN that can read how individual cells burn energy and use nutrients, even when looking at thousands of cells at once. By analyzing the genes that cells turn on and off, MeRN figures out which metabolic pathways (the chemical processes cells use to stay alive) are active in each cell. Gram Research analysis shows this tool helped researchers understand why folate deficiency causes birth defects, how immune cells respond differently to the same signals, and which metabolic changes help cancer cells resist treatment. This breakthrough could help doctors understand diseases better and develop new treatments.
Key Statistics
A 2026 computational study published on bioRxiv introduced MeRN, a tool that analyzes single-cell gene activity to predict hundreds of metabolic reactions simultaneously across individual cells.
MeRN identified that folate deficiency causes a break in de novo purine synthesis during embryonic neural tube development, linking a specific nutrient deficiency to a metabolic failure and birth defects.
The tool discovered that cytokines with similar non-metabolic effects trigger divergent metabolic responses in T cells, explaining why the same immune signal can have different outcomes in different contexts.
MeRN identified metabolic drivers of T cell exhaustion and therapy response in human cancer samples, suggesting the tool could predict which patients respond to immunotherapy based on cancer cell metabolism.
The Quick Take
- What they studied: Can scientists create a computer program that figures out how individual cells are using energy and nutrients by looking at which genes they turn on and off?
- Who participated: The researchers tested their tool on cells from mouse intestines, developing mouse embryos, immune cells called T cells, and cancer patient samples. No human subjects were directly studied; instead, researchers analyzed existing cell data.
- Key finding: MeRN successfully identified how different cell types use energy differently, discovered that folate deficiency breaks a specific energy-making pathway during fetal development, and found that cancer cells change their metabolism to escape immune attack.
- What it means for you: This tool could help doctors understand why certain diseases happen and predict which patients will respond to cancer treatments. However, this is early-stage research, and the tool needs more testing before it changes medical practice.
The Research Details
Researchers built a computer program called MeRN that works like a translator between gene activity and cell metabolism. The program uses something called a graph-guided variational autoencoder, which is a type of artificial intelligence that learns patterns from data while following a map of how metabolic pathways connect to each other. Think of it like teaching a computer to read a recipe book: the computer learns which ingredients (genes) are needed for each dish (metabolic process) by studying many examples.
The researchers tested MeRN on different types of cells to see if it could correctly identify which energy-making pathways were active. They looked at cells from mouse intestines (which have different metabolic zones), developing embryos, immune cells, and cancer samples. For each test, they compared what MeRN predicted to what scientists already knew about those cells.
What makes MeRN special is that it doesn’t rely on old textbook definitions of metabolic pathways. Instead, it discovers new pathway combinations that actually exist in real cells. The researchers called these discoveries data-driven pathways, or DDPs, because they come directly from what the cells are actually doing.
Understanding cell metabolism is like understanding a factory’s power system. When something goes wrong with metabolism, diseases happen. But measuring metabolism in individual cells has been nearly impossible because cells are so tiny and metabolism happens so fast. MeRN solves this by using gene activity as a fingerprint of metabolism. Since scientists can now measure genes easily, this tool opens a new window into how cells work.
This is a computational study, meaning researchers developed and tested a computer tool rather than running a traditional experiment. The strength of this work comes from testing MeRN on multiple different cell types and comparing results to known biology. The researchers showed their tool could recover known metabolic patterns (like in the intestine) and discover new ones (like in cancer immunity). However, because this is a preprint posted before peer review, the findings haven’t yet been checked by independent scientists. The tool’s predictions should be confirmed with additional experiments before being used in clinical settings.
What the Results Show
MeRN successfully identified how cells in the mouse intestine organize their metabolism into different zones, matching what scientists already knew about intestinal structure. This validation showed the tool works correctly on real biological systems.
When researchers applied MeRN to developing embryos, it discovered something important: folate deficiency breaks a specific pathway that makes purines (building blocks for DNA). This break happened exactly during the time when neural tube defects (birth defects of the brain and spine) develop. This finding connects a nutrient deficiency to a specific metabolic failure and a birth defect, providing a new understanding of how folate prevents these defects.
In immune cells called T cells, MeRN revealed that different chemical signals (cytokines) that seem similar in their effects actually cause cells to use energy in completely different ways. This explains why the same signal can have different outcomes in different situations.
Most importantly for cancer patients, MeRN identified specific metabolic changes that happen when T cells become exhausted (stop fighting cancer) and when regulatory T cells adapt to support tumors. The tool also predicted which patients would respond to immunotherapy based on their cancer cells’ metabolic patterns.
The researchers introduced a new analysis method called weakest link analysis that finds where metabolic networks break down or rewire. This helps identify which metabolic steps are most vulnerable in disease. The tool also discovered that standard textbook metabolic pathways don’t always match what actually happens in real cells, suggesting that cells use customized metabolic combinations for their specific jobs.
Previous methods for studying cell metabolism either looked at many cells together (losing individual cell information) or measured only a few metabolic molecules at a time. MeRN combines the best of both approaches: it analyzes individual cells while predicting hundreds of metabolic reactions simultaneously. The tool builds on recent advances in artificial intelligence and single-cell gene analysis, bringing these technologies together in a new way.
This study tested MeRN on existing data rather than generating new experimental data. The tool’s predictions are based on gene activity, which is a proxy for metabolism, not a direct measurement. Some metabolic processes happen through proteins and molecules that don’t require gene changes, so MeRN might miss those. The study focused mainly on mouse cells and cancer samples, so the tool’s accuracy in other cell types and diseases remains unknown. Finally, because this is a preprint, the work hasn’t undergone peer review, and some findings may change after expert evaluation.
The Bottom Line
MeRN represents a promising new tool for understanding cell metabolism in research settings. Scientists should use it to explore metabolic changes in diseases they study. However, predictions from MeRN should be confirmed with additional experiments before making clinical decisions. Confidence level: moderate for research applications, low for clinical use at this stage.
Researchers studying cancer, immunology, birth defects, and metabolic diseases should pay attention to this tool. Doctors and patients should not yet use MeRN predictions to guide treatment decisions, as the tool needs more validation. Pharmaceutical companies developing new drugs might use MeRN to understand how their drugs affect cell metabolism.
If MeRN is validated in additional studies, it could influence cancer treatment decisions within 2 to 5 years. Understanding of metabolic diseases could improve within 1 to 3 years as researchers apply the tool. Clinical applications would likely take 5 to 10 years of additional research and testing.
Frequently Asked Questions
How can scientists measure metabolism in individual cells?
MeRN uses gene activity as a fingerprint of metabolism. By analyzing which genes cells turn on and off, the tool predicts which metabolic pathways are active. This works because genes control the proteins that run metabolic processes.
What is folate deficiency and why does it cause birth defects?
Folate is a B vitamin needed to make DNA building blocks called purines. MeRN showed that folate deficiency breaks the pathway that makes these blocks, preventing proper brain and spine development during pregnancy.
Can this tool help predict cancer treatment response?
MeRN identified metabolic changes in cancer cells that relate to treatment response and immune cell exhaustion. The tool shows promise for predicting which patients respond to immunotherapy, but needs more testing before clinical use.
Why do immune cells respond differently to the same signal?
MeRN discovered that T cells use completely different metabolic strategies when exposed to similar immune signals. This explains why identical signals produce different outcomes depending on the cell’s metabolic state and context.
When will doctors use this tool to treat patients?
MeRN is currently a research tool that needs additional validation. Clinical applications would likely take 5 to 10 years of further research, testing, and regulatory approval before doctors could use it to guide treatment decisions.
Want to Apply This Research?
- Track metabolic health markers that relate to your condition: for cancer patients, monitor immune cell counts and treatment response; for those with metabolic concerns, track energy levels and nutrient intake daily.
- Users could log their nutrient intake (especially folate-rich foods) and energy levels to see personal patterns. The app could provide reminders about foods that support healthy cell metabolism based on their health goals.
- Set up monthly check-ins to review metabolic markers from blood tests or health data. Compare patterns over time to see if dietary or lifestyle changes affect your metabolic health. Share trends with your doctor to inform treatment decisions.
This research describes a computational tool for analyzing cell metabolism and is published as a preprint before peer review. MeRN’s predictions are based on gene activity patterns and should not be used to make medical decisions without confirmation through additional experiments and clinical validation. The findings about folate deficiency and birth defects are based on computational analysis of existing data, not direct human studies. Anyone concerned about folate intake during pregnancy should consult their healthcare provider. Cancer patients should not change treatment decisions based on this research alone; discuss any metabolic or treatment-related questions with their oncology team. This article is for educational purposes and does not constitute medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.